Get started
Author

Romeo A. Mandanas

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
2019 · Cathy Eng, Tae Won Kim, et al. · The Lancet Oncology · 579
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
1996 · J Beyer, A Kramar, et al. · Journal of Clinical Oncology · 322
Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
2012 · David J. Kuter, Susan D. Mathias, et al. · American Journal of Hematology · 79
Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors
2001 · M. C. Foncuberta, P. J. Cagnoni, et al. · Journal of Immunotherapy · 52
Bullous esophagitis due to chronic graft-versus-host disease.
1997 · A Minocha, R A Mandanas, et al. · PubMed · 34
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
1995 · E R Broun, C R Nichols, et al. · PubMed · 30
Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma
2010 · Robert Rifkin, Gary Spitzer, et al. · Clinical Lymphoma Myeloma & Leukemia · 19
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: Examination of a preemptive plan of ganciclovir therapy
1996 · Romeo A. Mandanas, Ruben A. Saez, et al. · American Journal of Hematology · 18
PDF
Phase II Trial of Cimetidine in Metastatic Melanoma
1991 · Romeo Mandanas, Stephen Schultz, et al. · American Journal of Clinical Oncology · 17
Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer
2013 · Philip D. Bonomi, Joseph Mace, et al. · Journal of Thoracic Oncology · 15
Impaired Gastric Slow Wave Rhythmicity in Patients After Bone Marrow or Stem Cell Transplant
2002 · Xiaohong Xu, Romeo A. Mandanas, et al. · Digestive Diseases and Sciences · 13
Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation
2000 · Anthony M Abang, Marc H Takemoto, et al. · Anti-Cancer Drugs · 10
Carboplatin (CBDCA) Plus Alpha Interferon In Metastatic Non-Small Cell Lung Cancer
1993 · Romeo Mandanas, Lawrence H. Einhorn, et al. · American Journal of Clinical Oncology · 10
G-CSF-Mobilized Donor Leukocyte Infusions as Immunotherapy in Acute Leukemia Relapsing After Allogeneic Marrow Transplantation
1998 · Romeo A. Mandanas, Ruben A. Saez, et al. · Journal of Hematotherapy · 8
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response
2010 · Robert M. Rifkin, Andrew Greenspan, et al. · Investigational New Drugs · 6
Autologous bone marrow transplantation for metastatic breast cancer.
1994 · R A Saez, G B Selby, et al. · PubMed · 5
A Randomized, Multicenter, Open-Label Comparison of the Antiemetic Efficacy of Dolasetron Versus Ondansetron for the Prevention of Nausea and Vomiting During High-Dose Myeloablative Chemotherapy
2005 · Romeo A. Mandanas, Roy Beveridge, et al. · Supportive Cancer Therapy · 4
Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).
2009 · Roger M Lyons, Ralph V. Boccia, et al. · Blood · 3
Pegfilgrastim (neulasta™) following chemotherapy leads to successful mobilization of hematopoietic progenitor cells among transplant patients with various diagnoses
2004 · R.A. Mandanas, B.J. Underwood, et al. · Transplantation and Cellular Therapy · 3
Patient Quality of Life (QOL) In Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care (SOC)
2010 · Mathias J. Rummel, David J. Kuter, et al. · Blood · 2
Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP),
2011 · Jeffrey Wasser, Ralph Vincent V. Boccia, et al. · Blood · 1
Autologous bone marrow transplantation for non-Hodgkin lymphoma.
1994 · R A Saez, R B Slease, et al. · PubMed · 1
Biomarker distribution and characteristics for the first 100 patients in MAVERICC, a randomized phase II study of mFOLFOX6-bevacizumab (BV) versus FOLFIRI-BV in previously untreated metastatic colorectal cancer (mCRC).
2013 · Alexander Starodub, Sachdev P. Thomas, et al. · Journal of Clinical Oncology
Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response
2008 · Robert M. Rifkin, Gary Spitzer, et al. · Blood
79: Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma: Results of a Randomized Phase II Trial
2008 · R. Rifkin, R. Beveridge, et al. · Transplantation and Cellular Therapy
PDF
Works count: 32
Citation count: 1,231
H-index: 11
I10-index: 13
Year
Topic
Type